Flossbach Von Storch Ag Bio N Tech Se Transaction History
Flossbach Von Storch Ag
- $25.3 Billion
- Q3 2024
A detailed history of Flossbach Von Storch Ag transactions in Bio N Tech Se stock. As of the latest transaction made, Flossbach Von Storch Ag holds 4,359,607 shares of BNTX stock, worth $532 Million. This represents 2.05% of its overall portfolio holdings.
Number of Shares
4,359,607
Previous 4,379,483
0.45%
Holding current value
$532 Million
Previous $352 Million
47.13%
% of portfolio
2.05%
Previous 1.49%
Shares
11 transactions
Others Institutions Holding BNTX
# of Institutions
358Shares Held
38.4MCall Options Held
2.45MPut Options Held
2.29M-
Baillie Gifford & CO8.31MShares$1.01 Billion0.75% of portfolio
-
Primecap Management CO Pasadena, CA4.52MShares$552 Million0.4% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$231 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$221 Million0.88% of portfolio
-
Capital International Investors Los Angeles, CA1.02MShares$125 Million0.02% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $29.6B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...